meta_analysis
    2022

    Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis

    Dutta T, Anand U, Mitra SS, Ghorai M, Jha NK

    Published in Frontiers in Pharmacology

    Methodology

    Systematic review and meta-analysis of randomised controlled and open-label trials of herbal remedies in children and adolescents with ADHD; seven RCTs met inclusion criteria.

    Key Findings

    There is a fair indication of the efficacy and safety of Melissa officinalis, Bacopa monnieri, Matricaria chamomilla and Valeriana officinalis from the studies evaluated, but the evidence base is limited.

    Conclusions

    Herbal treatments including Bacopa show preliminary promise for ADHD symptoms, though safety and efficacy require further investigation.

    Limitations

    Few small trials; heterogeneous preparations and outcome scales; inclusion of open-label studies; risk of bias not uniformly low.

    Supplements Studied

    There is a fair indication of the efficacy and safety of Melissa officinalis L., Bacopa monnieri (L.) Wettst., Matricaria chamomilla L., and Valeriana officinalis L. from the studies evaluated.

    Related Health Concerns

    Study Details

    Year:2022
    Quality Score:6/10

    Disclosures

    Funding

    Not reported

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.